Sensex Plunges Over 400 Points; Broader Markets Outperform
The benchmark indices have plunged nearly 1 per cent in early noon trading, dragged by weakness in select banking and information technology stocks. At 12:15 pm, the BSE Sensex was trading at 51,538.75, weaker by 403.05 points or 0.78 per cent and the NSE Nifty was at 15,485.10, down 90.30 points or 0.58 per cent. The broader markets were defying the weak trend, with the BSE Midcap index and BSE Smallcap index gaining 1 per cent each.
On the currency front, the rupee slumped 27 paise to 73.17 against the US dollar in opening trade on Wednesday tracking weak domestic equities and strong American currency. At the interbank foreign exchange, the rupee opened lower at 73.13 against the dollar and lost further ground thereafter.
Meanwhile, MTAR Technologies, Muthoot Finance and PVR are scheduled to release their quarterly earnings during the day.
On the stock-specific front, ITC was top loser on the BSE. The stock fell as much as 2.76 per cent to hit an intraday low of Rs 209.30 a day after the FMCG major reported net profit of Rs 3,748 crore in the quarter ended March 2021, marking a decline of 1.3 per cent compared to the same quarter last year.
Information technology stocks were trading lower, with Tech Mahindra, TCS, Infosys and HCL Technologies losing around a per cent each on the BSE. The private banking space was also seeing some pressure, with the likes of HDFC, HDFC Bank, Axis Bank and ICICI Bank shedding around a per cent each on the BSE.
On the flip side, Power Grid, NTPC, Sun Pharma and SBI gained around half a per cent each on the BSE.
The BSE market breadth was strong. Out of 3,118 stocks traded on the BSE, there were 1950 advancing stocks as against 1021 declines.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.